A biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin's R&D activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California.
Post new comment